Blood Transfusion Diagnostics Market Size & Growth Report 2028

[Research Report] The blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028.

Blood transfusion diagnostics are tests performed on blood before they are transfused to patients. A blood transfusion is a common procedure in which the donated blood or its components are transfused into the patient’s body through an intravenous route of administration. Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection.

The report offers insights and in-depth analysis of the global blood transfusion diagnostics market, emphasizing various parameters, including market trends, technological advancements, market dynamics, and competitive landscape analysis of global leading market players. It also includes the impact of the COVID-19 pandemic on the market across all regions. The COVID-19 pandemic negatively impacted the global blood transfusion diagnostics market growth. It showcased a huge decline in revenue due to stringent restrictions imposed by the government resulting in decreasing number of surgical procedures performed. These services are mainly used in surgeries with high blood loss, such as orthopedic and cardiac surgeries. Due to decreasing number of surgeries performed, the demand for blood transfusion has reduced. For Instance: According to the data published by American Medical Association, it was estimated that there was a 48% reduction in total surgical procedures performed in the US due to the COVID-19 pandemic. However, after the pandemic restrictions normalized, the volume of surgical procedures returned to normal levels.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Blood Transfusion Diagnostics Market: Strategic Insights

Blood Transfusion Diagnostics Market

• 
  CAGR (2021 - 2028)

  6.9%
• Market Size 2021
  US$ 4.1 Billion
• Market Size 2028
  US$ 6.48 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Grifols S A
• F Hoffmann La Roche Ltd
• Immucor Inc
• Bio Rad Laboratories Inc
• Abbott
• Thermo Fisher Scientific Inc
• Ortho Clinical Diagnostics
• DiaSorin S p A
• Quotient Limited

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Instruments & Kits and Reagents

Application

• Disease Screening and Blood Grouping

End User

• Hospitals
• Diagnostic Laboratories
• Plasma Fractionation Companies

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Geography-Based Insights

By geography, the global blood transfusion diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Market Insights

Need for Blood Transfusion due to Rise in Organ Transplants Surgeries

Organ transplant is a surgical procedure performed in case of organ failure. Usually, organ transplant surgeries are conducted for the heart, liver, kidney, and various other organs due to the rising cases of chronic diseases, such as chronic kidney disease (CKD), polycystic kidney disease, cystic fibrosis, and congenital heart disease, which require transplants. These procedures generally take hours, and there is a lot of blood loss and requires the need for blood transfusion. For instance, according to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all organ donations in Europe in 2019 and 6% worldwide. Australia's organ donor rate has improved recently, rising to 21.8 donors per million population in 2019.

Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the "Donation Physicians" figure—intensive care doctors responsible for organ donation. According to the World Transplant Registry, China had 5,818 donors in 2019, or 4.1 per million population, and India had 715 donors, or 0.5 per million population in 2019. On the other hand, Russia had a slightly higher rate of 5.1 donors per million people. The public-private partnership, in collaboration with transplant coordinators, has significantly contributed to the improvement of organ transplants requiring constant blood transfusion. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries, such as India and Singapore, are emerging as medical tourism  destinations in Asia Pacific. Countries are progressing in terms of providing better and advanced medical treatments. The rising need for organ transplants is among the key factors driving the demand for blood transfusion diagnostics worldwide.

Product-Based Insights

Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. In 2021, the instruments & kits segment accounted for a larger market share. The same segment is expected to register a higher CAGR in the market from 2022 to 2028.

Application-Based Insights

Based on application, the global blood transfusion diagnostics market is bifurcated into disease screening and blood grouping. The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period.

Blood Transfusion Diagnostics Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

End User-Based Insights

Based on end user, the global blood transfusion diagnostics market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation  companies. The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the market from 2022 to 2028.

The global blood transfusion diagnostics market players take up organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demand. The key players in the market are Grifols, S.A.; F. Hoffmann-La Roche Ltd; Immucor, Inc.; Bio-Rad Laboratories, Inc.; Abbott; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; DiaSorin S.p.A.; Quotient Limited; and BAG Diagnostics GmbH.